Investigation of oxidant and antioxidant levels in patients with psoriasis
- PMID: 31269785
- PMCID: PMC7018382
- DOI: 10.3906/sag-1807-257
Investigation of oxidant and antioxidant levels in patients with psoriasis
Abstract
Background/aim: Psoriasis is an immune-mediated chronic inflammatory skin disease that is seen in 1%–3% of the population. It is characterized by symmetrical papulosquamous lesions on the scalp, knees, elbows, sacral region, and extensor surfaces of the extremities. Psoriasis affects both sexes equally. It is thought that reactive oxygen species have an important role in inflammatory skin diseases, especially in psoriasis. There are few studies investigating serum oxidant-antioxidant levels in psoriasis. In this study, we aimed to investigate serum oxidant and antioxidant levels in psoriasis and their effects on its pathogenesis.
Materials and methods: Included in this study were 50 patients with psoriasis who had not been treated with any systemic medication and 45 healthy volunteers (control group). The total oxidant status (TOS), total antioxidant status (TAS), malondialdehyde (MDA), and 8-hydroxy 2’-deoxyguanosine (8H2D) were studied via venous blood sampling. The parameters were measured spectrophotometrically. The study was approved by the Local Ethics Committee of the Atatürk University Faculty of Medicine.
Results: The mean ages of the patients and control group were 32.48 (±14.45) and 35.64 (±17.40) years, respectively. Of the patients, 23 were male and 27 were female. Of the healthy volunteers, 20 were male and 25 were female. The mean disease duration was 8.77 (±6.90) years. The mean Psoriasis Area and Severity Index (PASI) score was 11.41 (±9.62). The mean TOS levels of the patient and control groups were 63.12 (±33.23) and 4.50 (±9.74), respectively. This difference was statistically significant (P = 0.00). The mean TAS levels of the patient and control groups were 3.15 (±0.70) and 3.16 (±0.44), respectively, without any statistically significant difference. The mean MDA levels in the patient and control groups were 14.84 (±6.66) and 12.77 (±4.87), respectively, without any statistically significant difference. The mean 8H2D levels of the patient and control groups were 16,781.2 (±5918.95) and 15,276.13 (±6084.95), respectively. This difference was also not statistically significant. There was no correlation between PASI scores and the above-mentioned parameters.
Conclusion: In the present study, the TOS levels showed a significant statistical difference between the psoriasis and control groups. This finding supports the effect of the oxidant system in the pathogenesis of psoriasis. This was the first study to investigate MDA, TOS, TAS, and 8H2D levels together in patients with psoriasis. More studies are needed to clearly understand the relationship between psoriasis and the oxidant-antioxidant system.
Keywords: Psoriasis; total oxidant status; total antioxidant status; malondialdehyde; 8-hydroxy 2’-deoxyguanosine.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Conflict of interest statement
none declared
Similar articles
-
Unraveling Mitochondrial Reactive Oxygen Species Involvement in Psoriasis: The Promise of Antioxidant Therapies.Antioxidants (Basel). 2024 Oct 11;13(10):1222. doi: 10.3390/antiox13101222. Antioxidants (Basel). 2024. PMID: 39456475 Free PMC article. Review.
-
Oxidant / antioxidant status in patients with psoriasis.Yonsei Med J. 2003 Dec 30;44(6):987-90. doi: 10.3349/ymj.2003.44.6.987. Yonsei Med J. 2003. PMID: 14703605
-
Association of total oxidant status, total antioxidant status, and malondialdehyde and catalase levels with psoriasis: a systematic review and meta-analysis.Clin Rheumatol. 2019 Oct;38(10):2659-2671. doi: 10.1007/s10067-019-04676-1. Epub 2019 Jul 18. Clin Rheumatol. 2019. PMID: 31321579
-
Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease?J Periodontol. 2014 Oct;85(10):1432-41. doi: 10.1902/jop.2014.130654. Epub 2014 Mar 17. J Periodontol. 2014. PMID: 24635543
-
Antioxidant potential of propylthiouracil in patients with psoriasis.Clin Biochem. 2002 May;35(3):241-6. doi: 10.1016/s0009-9120(02)00294-1. Clin Biochem. 2002. PMID: 12074833 Clinical Trial.
Cited by
-
Oxidative Imbalance in Psoriasis with an Emphasis on Psoriatic Arthritis: Therapeutic Antioxidant Targets.Molecules. 2024 Nov 19;29(22):5460. doi: 10.3390/molecules29225460. Molecules. 2024. PMID: 39598849 Free PMC article. Review.
-
Unraveling Mitochondrial Reactive Oxygen Species Involvement in Psoriasis: The Promise of Antioxidant Therapies.Antioxidants (Basel). 2024 Oct 11;13(10):1222. doi: 10.3390/antiox13101222. Antioxidants (Basel). 2024. PMID: 39456475 Free PMC article. Review.
-
Psoriasis and COVID-19: A narrative review with treatment considerations.Dermatol Ther. 2020 Nov;33(6):e13858. doi: 10.1111/dth.13858. Epub 2020 Jul 9. Dermatol Ther. 2020. PMID: 32686245 Free PMC article. Review.
-
The Involvement of Oxidative Stress in Psoriasis: A Systematic Review.Antioxidants (Basel). 2022 Jan 29;11(2):282. doi: 10.3390/antiox11020282. Antioxidants (Basel). 2022. PMID: 35204165 Free PMC article. Review.
-
Changes in Proteome of Fibroblasts Isolated from Psoriatic Skin Lesions.Int J Mol Sci. 2020 Jul 28;21(15):5363. doi: 10.3390/ijms21155363. Int J Mol Sci. 2020. PMID: 32731552 Free PMC article.
References
-
- Schon MP Boehncke WH Psoriasis. New England Journal of Medicine. 2005;352:1899. - PubMed
-
- Krueger G Ellis CN Psoriasis recent advances in understanding its pathogenesis and treatment. Journal of the American Academy of Dermatology. 2005;53:94. - PubMed
-
- Reynoso-von Drateln C Martinez-Abundis E Balcazar-Munoz BR Bustos-Saldana R Gonzalez-Ortiz M Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. Journal of the American Academy of Dermatology. 2003;48:882. - PubMed
-
- Baz K Cimen B Kokturk A Yazici AC Eskandari G Oxidant/antioxidant status in patients with psoriasis. Yonsei Medical Journal. 2003;44:987. - PubMed
-
- Severin E Nave B Stander M Ott R Traupe H Total antioxidative capacity is normal in sera from psoriasis patients despite elevated bilirubin, tocopherol, and urate levels. Dermatology. 1999;198:336. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical